| COVID-19 and healthcare impacts | Lifetime | 31 | US 12 | 99.07 |
| Economic and Financial Impacts of Cancer | Lifetime | 16 | US 12 | 99.58 |
| Global Cancer Incidence and Screening | Lifetime | 43 | US 18 | 99.57 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 126 | US 61 | 99.54 |
| Multiple and Secondary Primary Cancers | Lifetime | 33 | US 13 | 99.51 |
| Colorectal Cancer Screening and Detection | Lifetime | 111 | US 56 | 99.41 |
| Palliative Care and End-of-Life Issues | Lifetime | 125 | US 67 | 99.12 |
| Cancer survivorship and care | Lifetime | 129 | US 73 | 98.88 |
| Healthcare Policy and Management | Lifetime | 217 | US 161 | 98.68 |
| Childhood Cancer Survivors' Quality of Life | Lifetime | 284 | US 160 | 98.49 |
| Family Support in Illness | Lifetime | 314 | US 161 | 96.82 |
| Cervical Cancer and HPV Research | Lifetime | 891 | US 380 | 96.51 |
| Healthcare cost, quality, practices | Lifetime | 449 | US 248 | 94.70 |
| Pharmaceutical Economics and Policy | Lifetime | 968 | US 396 | 91.22 |
| COVID-19 and healthcare impacts | 2021-2025 | 10 | US 4 | 99.38 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 4 | US 4 | 99.73 |
| Global Cancer Incidence and Screening | 2021-2025 | 7 | US 4 | 99.63 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 19 | US 6 | 99.52 |
| Healthcare Policy and Management | 2021-2025 | 5 | US 5 | 99.00 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 5 | US 3 | 99.32 |
| Palliative Care and End-of-Life Issues | 2021-2025 | 24 | US 13 | 99.02 |
| Healthcare cost, quality, practices | 2021-2025 | 8 | US 1 | 98.11 |
| Cancer survivorship and care | 2021-2025 | 34 | US 15 | 98.66 |
| Childhood Cancer Survivors' Quality of Life | 2021-2025 | 74 | US 53 | 98.14 |
| Colorectal Cancer Screening and Detection | 2021-2025 | 216 | US 76 | 96.17 |
| Health disparities and outcomes | 2021-2025 | 494 | US 184 | 93.59 |
| Global Health Care Issues | 2021-2025 | 228 | US 46 | 90.18 |
| Adolescent and Pediatric Healthcare | 2021-2025 | 446 | US 181 | 87.10 |
| Family Support in Illness | 2021-2025 | 453 | US 144 | 84.67 |
| Pharmaceutical Economics and Policy | 2021-2025 | 532 | US 180 | 79.55 |
| Advances in Oncology and Radiotherapy | 2021-2025 | 560 | US 265 | 76.86 |
